Related Experiment Video
Updated: Aug 11, 2026
07:00
Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
Published on: August 11, 2017
Benefits of certification for pharmacy specialists
1Northwest Texas Hospital, Amarillo, USA.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|February 1, 1996
Summary
Board of Pharmaceutical Specialties (BPS) certification offers pharmacists significant intangible benefits like increased self-worth and marketability, though tangible rewards such as raises are less common. This study surveyed BPS-certified pharmacists to quantify these advantages.
Area of Science:
- Pharmacology
- Pharmacy Practice
- Professional Development
Background:
- The Board of Pharmaceutical Specialties (BPS) offers specialized certification for pharmacists.
- Understanding the benefits of BPS certification is crucial for career advancement and professional recognition.
Purpose of the Study:
- To measure the tangible and intangible benefits experienced by pharmacists holding Board of Pharmaceutical Specialties (BPS) certification.
- To compare perceived benefits across different specialties and degree holders.
Main Methods:
- A survey was mailed to 733 BPS-certified pharmacists in October 1933.
- A response rate of 65.5% (n=480) was achieved.
- Data analysis involved comparing responses based on specialty and degree type.
Main Results:
- Approximately 8% reported a promotion, 16% a bonus, and 10% a raise directly linked to certification.
- Highest agreement on perceived benefits included greater self-worth, improved competence, and enhanced marketability.
- Monetary compensation showed the lowest agreement among reported benefits.
Conclusions:
- BPS certification significantly enhances pharmacists' perceived self-worth, competence, and marketability.
- While direct monetary benefits are less frequently reported, the intangible advantages are substantial.
- Further research can explore the long-term career impact of BPS certification across diverse pharmacy roles.
Related Concept Videos
01:30Specialized Care Centers and Settings-II
Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...